Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 37

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Fluoroquinolone resistance in urinary tract infections: Epidemiology, mechanisms of action and management strategies

Thompson, Daryl, Xu, Jennifer, Ischia, Joseph, Bolton, Damien·2024·BJUI Compass

Abstract

Background: Fluoroquinolone resistance is an issue of concern amongst physicians worldwide. In urology, fluoroquinolones are often used in the treatment of acute pyelonephritis and prostatitis, as well as infections caused by multidrug‐resistant pathogens. Aims: We aim to highlight the importance of antimicrobial stewardship and the need for ongoing biomedical research to discover novel agents in our losing battle against resistant pathogens. Materials and methods: In this review, we survey the literature and summarise fluoroquinolone resistance as it pertains to pyelonephritis and prostatitis, as well as alternative treatment strategies and prevention of multidrug resistance. Results: The rise of fluoroquinolone resistance in bacteria has reduced the available treatment options, often necessitating hospital admission for intravenous antibiotics, which places an additional burden on both patients and the healthcare system. Many countries such as Australia have attempted to limit fluoroquinolone resistance by imposing strict prescribing criteria, though these efforts have not been entirely successful. Solutions to overcome resistance include prevention, combination therapy and the development of novel antimicrobial agents. Conclusions: Prevention of the proliferation of resistant organisms by antimicrobial stewardship is paramount, and urologists are obliged to be aware of responsible prescribing practices such as referring to local guidelines when prescribing. By reserving fluoroquinolones for infections in which they are truly indicated and by prescribing based on both patient and local environmental factors, we can preserve this effective resource for future use.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/bco2.286

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 46

  1. Hooper DC, 1987, Mechanisms of action of and resistance to ciprofloxacin, Am J Med, 82, 12
  2. 10.1093/jac/dki169 · DOI
  3. Pourahmad Jaktaji R, 2013, Study the expression of marA gene in ciprofloxacin and tetracycline resistant mutants of Escherichia coli, Iran J Pharm Res, 12, 923
  4. 10.1099/jmm.0.000873 · DOI · Paper page
  5. 10.1016/j.tim.2018.06.007 · DOI · Paper page
  6. 10.1093/jac/49.1.55 · doi:10.1093/jac/49.1.55
  7. Turnidge JD, 2013, Australian group on antimicrobial resistance community‐onset gram‐negative surveillance program annual report, 2010, Commun Dis Intell Q Rep, 37, E219, 10.33321/cdi.2013.37.33 · doi:10.33321/cdi.2013.37.33
  8. 10.1086/519268 · DOI · Paper page
  9. 10.3201/eid2209.160148 · DOI
  10. 10.1128/AAC.43.11.2736 · DOI · Paper page
  11. Kim J‐H, 2006, Quinolone resistance in community‐acquired acute pyelonephritis. Korean, J Nephrol, 571
  12. 10.1128/JCM.02594-14 · DOI
  13. 10.1592/phco.2005.25.10.1353 · DOI · Paper page
  14. 10.1016/j.juro.2010.11.088 · DOI · Paper page
  15. 10.1016/j.urology.2011.04.064 · doi:10.1016/j.urology.2011.04.064
  16. 10.1016/j.ijantimicag.2007.07.041 · doi:10.1016/j.ijantimicag.2007.07.041
  17. 10.1051/vetres:2001124 · DOI
  18. 10.1093/jac/dkq236 · DOI
  19. Bonkat G, 2018, Urological infections
  20. 10.1016/j.medmal.2014.02.003 · doi:10.1016/j.medmal.2014.02.003
  21. 10.3109/00365548.2011.572907 · DOI
  22. 10.1159/000444763 · DOI
  23. 10.1111/iju.12207 · doi:10.1111/iju.12207
  24. Park MG, 2019, Comparison of antibiotic susceptibility of Escherichia coli between community‐acquired and post‐prostate biopsy acute bacterial prostatitis, Arch Esp Urol, 72, 1018
  25. 10.1086/342955 · doi:10.1086/342955
  26. 10.1128/JCM.43.6.2962-2964.2005 · DOI
  27. 10.1086/323810 · doi:10.1086/323810
  28. 10.3343/alm.2014.34.4.286 · doi:10.3343/alm.2014.34.4.286
  29. 10.1016/S1473-3099(10)70027-X · DOI · Paper page
  30. 10.1592/phco.29.6.736 · doi:10.1592/phco.29.6.736
  31. 10.1186/s12957-019-1573-0 · DOI · Paper page
  32. 10.1111/bju.13402 · DOI
  33. Herness J, 2020, Acute pyelonephritis in adults: rapid evidence review, Am Fam Physician, 102, 173
  34. 10.1159/000049840 · DOI · Paper page
  35. 10.1007/s10156-007-0570-3 · doi:10.1007/s10156-007-0570-3
  36. 10.1093/jac/dkz015 · DOI
  37. 10.1128/AAC.01763-16 · doi:10.1128/aac.01763-16
  38. 10.1128/AAC.01011-16 · DOI
  39. 10.1128/AAC.01150-18 · doi:10.1128/aac.01150-18
  40. 10.1128/CMR.00031-19 · DOI · Paper page
  41. 10.1128/AAC.48.1.93-99.2004 · doi:10.1128/aac.48.1.93-99.2004
  42. 10.1086/652861 · doi:10.1086/652861
  43. 10.1097/00005392-199502000-00076 · doi:10.1097/00005392-199502000-00076
  44. 10.1016/S1569-9056(14)60562-5 · doi:10.1016/s1569-9056(14)60562-5
  45. 10.1111/j.1574-695X.2010.00723.x · DOI
  46. AURA, 2021, health

Cited by

See all 37

Metadata

Authors
Thompson, D., Xu, J., Ischia, J., & Bolton, D.
Affiliations
Department of Surgery The University of Melbourne, Austin Health Heidelberg Victoria Australia
Venue
BJUI Compass
Publisher
Wiley
Published
2023-08-31
Volume
5
Issue
1
Pages
5-11
ISSN
2688-4526
Cited by
37
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fluoroquinolone resistance in urinary tract infections: Epidemiology, mechanisms of action and management strategies. https://app.cochat.ai/papers/10.1002/bco2.286
The paper
Thompson, D., Xu, J., Ischia, J., & Bolton, D. (2024). Fluoroquinolone resistance in urinary tract infections: Epidemiology, mechanisms of action and management strategies. BJUI Compass. https://doi.org/10.1002/bco2.286

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.